Currently Viewing:
Newsroom
Currently Reading
Dr Yousuf Zafar of Duke Cancer Institute Joins The Samfund's Advisory Council
June 22, 2017 – AJMC Staff
Developing a Creative Strategy to Present the Value of Oncology Drugs
June 22, 2017 – Surabhi Dangi-Garimella, PhD
Research Warns Patients of Drug-Drug and Herb-Drug Interactions
June 21, 2017 – Christina Mattina
Asian Women Face Greater Barriers to Follow-up Care on Abnormal Mammogram
June 20, 2017 – Surabhi Dangi-Garimella, PhD
VA Pharmacy System Requires New Capabilities to Better Serve Veterans
June 20, 2017 – Alison Rodriguez
Diagnostic Test Brings a Precision Medicine Approach to Prostate Cancer Drug
June 19, 2017 – Surabhi Dangi-Garimella, PhD
European Commission Approves Second Biosimilar for Cancer Treatment Rituximab
June 19, 2017 – Christina Mattina
Instilling Value Early in Product Development: A Pharma Perspective
June 16, 2017 – Surabhi Dangi-Garimella, PhD
Older Patients Prefer to Base Cancer Screening Decisions on Health Status, Not Life Expectancy
June 15, 2017 – Christina Mattina

Dr Yousuf Zafar of Duke Cancer Institute Joins The Samfund's Advisory Council

AJMC Staff
Yousuf Zafar, MD, will advise The Samfund on research and evaluation of data to enhance its ability to combat financial aftereffects of cancer treatment.
The Samfund has announced the addition of Yousuf Zafar, MD, associate professor of medicine and public policy, and a gastrointestinal oncologist at the Duke Cancer Institute, to its advisory council. Zafar will advise The Samfund on research and evaluation of data to enhance its ability to combat financial aftereffects of cancer treatment.

Costs associated with cancer treatment can be a significant burden in a young adult cancer survivor’s life. Research conducted by The Samfund has found that the average net worth of a young adult cancer survivor receiving grants from the organization is approximately -$35,000, compared with $68,000 for young adults in the general population.

“While cancer treatment is evolving and improving, innovation comes at a high price,” Zafar said. "Every day, patients are making sacrifices to afford their cancer care. Not only do patients worry about the physical toxicity of cancer treatment, but they also have to worry about financial toxicity. I’m honored to be a part of The Samfund’s mission to reduce the financial toxicity experienced by cancer survivors and to ensure expenses do not stand between a patient and the best possible treatment.”

Communication gaps were also highlighted in the research that came out of The Samfund’s research study. Many young adults faced issues with initiating a conversation around finances with their doctors; they were ashamed or reluctant to start any financial conversation with their care provider. In his own research studies, Zafar has identified this disconnect—51% of cancer patients included in the study wanted to discuss cost considerations with their doctors, but only 19% actually do.

Samantha Watson, founder and CEO of The Samfund, said, “With Dr Zafar advising us on promoting adherence to medical treatment and new approaches to financial toxicity, we are better poised to help young adult survivors avoid it in the first place. We hear stories every day from individuals who are forgoing follow-up exams with their doctors, dental and mental health care, and facing hard choices between paying medical bills and their grocery bills.”

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up